We are live on ! Find out more
BNTX icon

BioNTech

254 hedge funds and large institutions have $4.97B invested in BioNTech in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 70 increasing their positions, 88 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 36

1.37% less ownership

Funds ownership: 22.37%21% (-1.4%)

2% less funds holding

Funds holding: 258254 (-4)

13% less capital invested

Capital invested by funds: $5.72B → $4.97B (-$750M)

20% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 88

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

29% less call options, than puts

Call options by funds: $113M | Put options by funds: $159M

Holders
254
Holders Change
-4
Holders Change %
-1.55%
% of All Funds
3.33%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
34
Increased
70
Reduced
88
Closed
36
Calls
$113M
Puts
$159M
Net Calls
-$45.9M
Net Calls Change
-$15.3M
Name Holding Trade Value Shares
Change
Change in
Stake
BG
76
Bellevue Group
Switzerland
$3.35M -$116K -1,084 -3%
SC
77
Scotia Capital
Ontario, Canada
$3.12M +$697K +6,519 +26%
CCP
78
Crocodile Capital Partners
Germany
$2.92M
Ameriprise
79
Ameriprise
Minnesota
$2.84M -$2.25K -21 -0.1%
UIM
80
USS Investment Management
United Kingdom
$2.74M
SGA
81
Sector Gamma AS
Norway
$2.73M -$1.04M -9,738 -26%
AC
82
Aristides Capital
Kentucky
$2.5M +$855K +8,000 +46%
LSA
83
Leonteq Securities AG
Switzerland
$2.38M +$1.24M +11,617 +93%
QOP
84
Quinn Opportunity Partners
Virginia
$2.27M -$222K -2,075 -8%
QC
85
Quadrature Capital
United Kingdom
$2.19M +$2.37M +22,203 New
VOYA Investment Management
86
VOYA Investment Management
Georgia
$2.11M -$307K -2,875 -12%
KCM
87
Kennedy Capital Management
Missouri
$2.06M +$482K +4,509 +27%
SG Americas Securities
88
SG Americas Securities
New York
$2.04M -$7.46M -69,726 -77%
Simplex Trading
89
Simplex Trading
Illinois
$2.01M +$1.36M +12,755 +168%
PAI
90
Palo Alto Investors
California
$1.93M -$598K -5,592 -22%
BPC
91
Banque Pictet & Cie
Switzerland
$1.9M +$1.52M +14,197 +278%
PFM
92
Privium Fund Management
Netherlands
$1.87M +$857K +8,013 +73%
LP
93
LMR Partners
United Kingdom
$1.83M +$325K +3,038 +20%
LPL Financial
94
LPL Financial
California
$1.81M -$141K -1,317 -7%
Mirae Asset Global ETFs Holdings
95
Mirae Asset Global ETFs Holdings
Hong Kong
$1.75M -$53.2K -498 -3%
SAM
96
Sectoral Asset Management
Quebec, Canada
$1.74M +$160K +1,500 +9%
CUAMC
97
China Universal Asset Management Company
China
$1.74M -$260K -2,431 -12%
IMC Chicago
98
IMC Chicago
Illinois
$1.72M +$1.86M +17,406 New
LIA
99
Limestone Investment Advisors
New York
$1.7M
PIM
100
Platinum Investment Management
Australia
$1.67M +$218K +2,039 +14%

BNTX Hedge Fund Activity: Q3 2025 in Review

254 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q3 2025, worth a combined $4.97B — down 13% from $5.72B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of BNTX and 34 opened new positions — a net loss of 2 holders — while 88 trimmed existing stakes and 70 added.

The largest buyer was Dodge & Cox, adding an estimated $296M. The largest seller was Fidelity Investments, cutting an estimated $289M.

  • 254 institutional investors held BioNTech (BNTX) as of Q3 2025, down from 258 in Q2 2025.
  • Funds reported $4.97B of BioNTech stock for Q3 2025, down 13% quarter-over-quarter.
  • 34 funds opened new BioNTech positions in Q3 2025 and 36 closed out, a net change of -2 holders.
  • The largest BioNTech buyer in Q3 2025 was Dodge & Cox, an estimated $296M added.
  • The largest BioNTech seller in Q3 2025 was Fidelity Investments, an estimated $289M sold.

Based on aggregated 13F filings for Q3 2025.